Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Multi-centric, Observational, Prospective Study to Collect the Criteria on Which Renewal of GnRH Analogue Treatment With Triptorelin (Diphereline 3.75mg or Diphereline pr 11.25mg) is Made in Patients Recently Diagnosed With Prostate Cancer Requiring Androgen Deprivation Therapy

NCT02238366 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT02238366
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02238366 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Multi-centric, Observational, Prospective Study to Collect the Criteria on Which Renewal of GnRH Analogue Treatment With Triptorelin (Diphereline 3.75mg or Diphereline pr 11.25mg) is Made in Patients Recently Diagnosed With Prostate Cancer Requiring Androgen Deprivation Therapy
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
November 30, 2013
Completion date
June 6, 2019
Enrollment
368 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer